Patients hoping to get their hands on a cheaper copycat of Johnson & Johnson’s fading anti-inflammatory blockbuster Simponi may have to wait for a few months more, thanks to an FDA inspection this summer that has derailed a leading biosimilar application from partners Teva and Alvotech.
Alvotech plant issues foil another FDA review, this time for Teva-partnered Simponi biosimilar
Latest from Blog
Why Walmart Moved ALOHA From the Nutrition Aisle to Grocery
Nosh spoke with company leaders about what prompted the move, how they’ll measure success and why they believe protein bars are increasingly becoming just another grocery staple. Post Views: 3
Fish Oil Supplements May Be A Bust For Alzheimer’s Prevention MedNews
FRIDAY, June 19, 2026 Millions of Americans take fish oil supplements hoping to keep their brains sharp as they age.But evidence just published in the journal E Post Views: 0
RFK Jr. Talks Nutrition In Holland
(Holland, MI) – U.S. Health and Human Services Secretary Robert F. Kennedy Jr. discussed nutrition and food ac… Post Views: 3
5 Risky Wellness Trends Doctors Want You to Avoid
Bee venom therapy and raw milk are among some of the worst wellness trends this year. Post Views: 3
Prehab Can Boost Seniors’ Recuperation From Spinal Fusion Surgery, Trial Finds MedNews
FRIDAY, June 19, 2026 Prehabilitation can help the elderly recover better and suffer fewer complications from spinal fusion surgery, a new study says.Patients 7 Post Views: 0